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In August 2018 a Moroccan man living in Tuscany devel-
oped  Plasmodium falciparum  malaria. The patient 
declared having not recently visited any endemic coun-
try, leading to diagnostic delay and severe malaria. As 
susceptibility to P. falciparum of Anopheles species in 
Tuscany is very low, and other risk factors for acquir-
ing malaria could not be completely excluded, the case 
remains cryptic, similar to other P. falciparum malaria 
cases previously reported in African individuals living 
in Apulia in 2017.
A case of severe  Plasmodium  falciparum  malaria was 
diagnosed in August 2018 in a Moroccan man living in 
Tuscany, Italy. Malaria was initially not considered by 
the managing clinicians because the patient reported 
to have not recently visited any endemic country, lead-
ing to diagnostic delay and severe anaemia. Here we 
describe the clinical and epidemiological features of 
this case and discuss different hypotheses on the pos-
sible route of transmission.
Case report
A previously healthy Moroccan man in his late 40s was 
admitted to an internal medicine ward of a tertiary 
hospital in Florence, Italy, in mid-August 2018, with a 
3-day history of high fever (> 38.5°C), headache, and 
mild cough. At physical examination, jaundice and 
splenomegaly were observed. Blood tests showed 
thrombocytopenia, haemolytic anaemia, and increased 
inflammatory markers (Table). A haematological dis-
ease was suspected, while malaria was initially not 
considered, since the patient declared to have not 
recently visited any endemic area. On Day 4 after 
admission, investigation for malaria was requested fol-
lowing an infectious diseases consultation. Thin blood 
smears revealed the presence of P. falciparum  tropho-
zoites with a parasitaemia of 0.5%. PCR confirmed  P. 
falciparum  mono-infection. The patient was referred 
to the Infectious and Tropical Diseases Unit with the 
diagnosis of severe malaria (haemoglobin (Hb) < 7 g/dL 
and parasitaemia > 0.2% [1]), and intravenous artesu-
nate was administered for 2 days, followed by oral 
dihydroartemisin-piperaquine for 3 days. Two units of 
packed red blood cells were transfused. The patient’s 
conditions improved and he was discharged a few days 
later. The case was notified to public health authorities 
(malaria is a mandatory notifiable disease in Italy) and 
microscopically confirmed by the National Institute of 
Health, Rome, Italy [2].
Epidemiological investigation
A careful history on possible malaria exposure was 
collected in collaboration with a Moroccan cultural 
mediator. The patient was born and had grown up in 
the Marrakesh-Safi Region, Morocco, before moving to 
Italy in 1990. He currently lives in an urbanised area 
of the province of Florence, Italy, about 10 km away 
from the city centre, where has been working, discon-
tinuously, as a construction worker. He denied previ-
ous blood transfusions and intravenous drug use. He 
reported a 1-month travel to Ghana looking for a job in 
2014. On that occasion, upon his arrival at Accra air-
port, he received an injection (probably, yellow fever 
vaccine) and was provided with some tablets (possibly 
antimalarial drug) that he took for about one week. 
During his stay in Ghana and thereafter, he did not 
present febrile diseases. He reported two to three trav-
els to Morocco per year, to visit relatives in his village 
of origin for periods of up to 2 months. He returned 
from his last travel to Morocco, arriving by plane from 
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Marrakech to Pisa in early June 2018, 73 days before 
the onset of symptoms. He slept one night in his resi-
dence near Florence, then moved by train to Viareggio, 
and subsequently worked outside as a beach vendor on 
the Tuscan coast during the summer. He stayed at the 
seaside and slept outdoors on the beach or in nearby 
places (for example in the pine forests along the coast, 
just behind the sand dunes), together with other beach 
vendors, including persons from Sub-Saharan Africa. 
The patient remembered many mosquito bites. He 
changed his location daily gradually moving south, and 
recalled having worked in beach resorts of Cecina, San 
Vincenzo, and Piombino, while he was not certain to 
have reached more southern beaches in the Maremma 
area. He returned to the starting point in Viareggio in 
mid-August. Then, he spent some time in a village near 
Bologna, and finally reached his home, 2 days later 
when he started to have fever in the afternoon. Over 
the whole summer, the patient worked and travelled 
with a group of newly-arrived men from Morocco who 
returned to their country on the day of fever onset in 
the patient; according to him all were in good health. 
No other information about them was available.
Discussion
Until the end of the 19th century, malaria was endemic 
in Italy, and the disease was responsible for ca 2 mil-
lion cases and 15,000–20,000 deaths per year [3]. The 
most affected areas were the Southern and Central 
Regions (including the Maremma area in the Tuscany 
Region), Sicily, and Sardinia [3-5]. P. falciparum malaria 
accounted for ca 20–30% of cases in several regions 
including in the Maremma area of Tuscany [3]. At that 
time the proven mosquito vectors present in Italy 
were  Anopheles labranchiae,  An. sacharovi, and  An. 
superpictus  [6]. Several initiatives to control malaria 
and its vectors were implemented during the 20th 
century, including the reclamation of swamps, the 
extensive use of chemical pesticides, and the exten-
sive delivery of quinine to the population [7]. These 
initiatives successfully led to a dramatic reduction 
of anopheline mosquitoes and to the elimination of 
the disease in 1970 [5]. Following the elimination, an 
increasing number of imported cases were reported in 
the country, in parallel to the rise of international travel 
and migratory flows, with ca 800 cases per year in the 
last two years [8].
An autochthonous introduced case of  P. vivax  malaria 
acquired in the Maremma area, Grosseto, Tuscany 
Table
Summary of main blood and urine investigations performed in the patient with Plasmodium falciparum malaria, Tuscany, 
Italy, August 2018
Parameters
Time after admission (Day 1) at the hospital in August 2018
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
White blood cells (x10^9/L) (norm: 4.00–10.00) 6.19 4.31 4.87 3.01 3.91 4.51
Haemoglobin (g/dL) (norm: 14–18) 12.1 10.5 9.7 6.9 8.9 8.8
Haematocrit (%) (norm: 42.0–52.0) 34.6 30 27.7 19.9 25.7 25.9
Platelet count (x10^9/L) (norm: 14–440) 65 44 70 79 101 261
Prothrombin time (%)(norm: 70–130) 62 61 69 70 ND ND
INR (norm: 0.8–1.2) 1.4 1.4 1.3 1.3 ND ND
Partial thromboplastin time (sec) (norm: 22–38) 27.1 27.5 27.7 27.1 ND ND
Fibrinogen (mg/dL) (norm: 200–400) 597 668 709 462 ND ND
Glucose (mg/dL) (norm: 65–110) 117 102 105 ND ND 82
Creatinine (mg/dL) (norm: 0.44–0.9 ) 0.92 0.93 0.97 0.91 0.77 0.69
Sodium (mEq/L) (norm: 135–145) 135 133 134 136 139 139
Potassium (mEq/L) (norm: 3.5–5) ND 3.4 3.8 3.6 4 3.9
Alanine aminotransferase (U/L) (norm: 12–65) 53 40 ND ND 40 18
Total bilirubin (mg/dL) (norm: 0.2–1) 3.2 3.1 4.2 2.0 ND ND
LDH (U/L) (norm: 84–246) ND 640 866 ND 733 ND
Haptoglobin (g/L) (norm: 0.3–2.0) ND < 0.078 ND ND ND ND
C-reactive protein (mg/L) (norm: <9) 148 ND ND ND 88 ND
Procalcitonin (ng/mL) (norm: <0.5) ND ND 5.09 ND 1.20 ND
Reticulocyte count (%) (norm: 0.5–2.5) ND 4.8 ND ND ND ND
HIV 1–2 Ag/Ag (norm: neg) ND ND ND Neg ND ND
Urine screening test for drugsa (norm: neg) ND ND ND Neg ND ND
Ag: antigen; HIV: human immunodeficiency virus; INR: international normalised ratio; LDH: lactate dehydrogenase; ND: not done; Neg: 
negative.
a Including amfetamine, benzodiazepine, cocaine, ecstasy, marijuana, methadone, opiates.
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Region was recorded in August 1997 [9]. In that case, 
the source of the infection was identified to be a par-
asitemic Indian girl living about 500 m away from the 
patient’s residence, who had recently returned from a 
travel to her country of origin [9]. Several mosquito-
breeding sites with  An. labranchiae  were identified 
during the entomological surveillance activities [9]. 
In separate events, another two potentially autoch-
thonous introduced  P. vivax  malaria cases were diag-
nosed, one in August 2009 and one in September 2011, 
however their source of infection remained unidenti-
fied [10]. The patients had likely been infected in the 
Agro Pontino area, Latium Region (2009 case), and 
in the Cosenza province, Calabria Region (2011 case), 
respectively. Entomological investigations were able 
to detect the presence of An. maculipenniss.s. and An. 
labranchiae in the two episodes, respectively [10].
In October 2017, four P. falciparum malaria cases were 
reported in the Apulia Region, in three Moroccan and 
one Sudanese immigrants without recent history of 
travel outside Italy (some of them visited Morocco 
previously) [7,11]. All the affected patients were farm 
workers in the Ginosa or Castellaneta countryside, 
Taranto province [11,12], where the presence of  An. 
labranchiae was confirmed by an entomological survey. 
All cases declared to have been in Italy for more than 
3 months prior to onset of symptoms [11,13]. Based 
on these findings, the European Centre for Disease 
Prevention and Control published two reports [11,14], 
and the United States Centers for Diseases Control and 
Prevention recommended ‘mosquito avoidance precau-
tion’ to travellers to agricultural areas of Ginosa [13].
In this report we describe a cryptic severe  P. falcipa-
rum malaria case observed in a Moroccan person living 
in Tuscany, Italy.
Morocco was certified as malaria free country in 
2010, not reporting autochthonous cases since 2007 
[15]. Imported  P. falciparum  malaria cases, mainly 
from Sub-Saharan Africa, are reported, and a risk of 
reintroduction is considered [16,17]. Our patient pre-
sented symptoms 73 days after leaving Morocco, mak-
ing it unlikely that the infection was acquired in Morocco 
since the incubation period for  P. falciparum  ranges 
in most cases from 9 to 30 days [18]. The possibility 
that the patient had been infected during a previous 
1-month stay in Ghana, in 2014, and had developed the 
disease after such a long incubation period appears 
unlikely, although it cannot be completely ruled out, as 
prolonged incubation has been reported in the recent 
literature [19]. On rare occasions, cases of  P. falcipa-
rum  malaria with delayed onset have been described 
in semi-immune migrants from endemic areas in which 
the immunity tends to wane years after migration [20]. 
The possibility of ‘airport malaria’ could be excluded, 
since the nearest airports to the Tuscany coast (Pisa 
and Grosseto) are at least ca 15 km far from the patient 
visited areas. Other travels to endemic areas and 
risk factors for induced malaria such as transfusion, 
transplant, nosocomial, intravenous drug use were 
denied by the patient. The possibility of transmission 
by an infected mosquito transported in a baggage can-
not be excluded [21].
Malaria competent vectors are present in Italy and, 
according to the latest available entomological 
data,  An. labranchiae  is present in Tuscany [10]. The 
level of competence of  An. labranchiae  to transmit  P. 
falciparum  is debated. Studies conducted on vecto-
rial capacity of Italian An. labranchiae showed that the 
species is poorly susceptible to infection with tropical 
or African  P. falciparum  strains [22-24]. Moreover, a 
study from 2012 assessed the malariogenic potential 
of the Maremma as very low, although the occurrence 
of sporadic, isolated cases of introduced  P. vivaxma-
laria was considered possible during the summer sea-
son, in presence of asymptomatic gametocyte carriers 
from endemic areas [24]. Concerning P. falciparum, the 
estimated vectorial capacity of anopheline population 
in Maremma is considered even lower [24].
The presented case, together with other  P. falcipa-
rum malaria cases recently reported from Apulia, may 
suggest the occurrence of sporadic autochthonous  P. 
falciparum during the summer season in Italy. However, 
considering that the susceptibility to  P. falcipa-
rum  infection of the anthropophilic Anopheles species 
present in Tuscany area is very low, and that the 
possibility of unrevealed risk factors for acquiring 
malaria cannot be completely excluded, the presented 
case remains cryptic. Some travellers may inadvert-
ently or deliberately fail to mention that they have 
recently been in an endemic area [25].
The fact that four patients recently diagnosed with  P. 
falciparum  malaria in Italy were Moroccan citizens 
remains difficult to explain, considering that Morocco 
is a malaria-free country. In our patient, malaria 
diagnosis was delayed because of the missing his-
tory of a recent visit to a malaria endemic area. In this 
perspective, clinicians should consider malaria as one 
possible differential diagnosis in patients with compat-
ible clinical and laboratory features, even if they do not 
report a clear exposure to endemic countries.
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